Latest Period
Q1 2026
Security Snapshot
Cellectar Biosciences, Inc. - Common Shares (CLRB) Institutional Ownership
CUSIP: 15117F880
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
300,336
Price
$2.54
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Shares
- Symbol
- CLRB on Nasdaq
- Shares outstanding
- 4,338,395
- Price per share
- $2.84
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 300,336
- Total reported value
- $762,852
- % of total 13F portfolios
- 0%
- Share change
- -46,018
- Value change
- -$145,445
- Number of holders
- 18
- Price from insider filings
- $2.84
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- CLRB - Cellectar Biosciences, Inc. - Common Shares is tracked under CUSIP 15117F880.
- 18 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 19 to 18 between Q4 2025 and Q1 2026.
- Reported value moved from $992,540 to $762,852.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 18 institutions filings for Q1 2026.
Security key
15117F880
Latest holder period
Q1 2026
13F holders
18
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
CLRB full holder history
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Cellectar Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F880:
Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hexstone Capital LLC | 4.9% | -12% | $553,293 | +$169,293 | 216,130 | +44% | Hexstone Capital LLC | 31 Dec 2025 |
| Bleichroeder LP | 4.6% | -24% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC | 5% | 140,101 | Mitchell P. Kopin | 01 Jul 2025 | ||||
| LYTTON LAURENCE W | 1.6% | $250,788 | 51,391 | LYTTON LAURENCE W | 30 Jun 2025 | |||
| Nantahala Capital Management, LLC | 0.06% | $5,412 | 1,109 | Nantahala Capital Management, LLC | 30 Jun 2025 |
As of 31 Mar 2026, 18 institutional investors reported holding 300,336 shares of Cellectar Biosciences, Inc. - Common Shares (CLRB). This represents 6.9% of the company’s total 4,338,395 outstanding shares.